Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350731 | 1.00 | TGFBR1 (1.00) | TGFBR1MAPK14 | |
| SCHEMBL21234477 | 0.89 | TGFBR1 (0.80) | TGFBR1MAPK14 | |
| SCHEMBL22477572 | 0.89 | TGFBR1 (0.79) | TGFBR1MAPK14 | |
| SCHEMBL29772701 | 0.87 | TGFBR1 (0.77) | TGFBR1MAPK14 | |
| SCHEMBL31256652 | 0.82 | TGFBR1 (0.70) | TGFBR1MAPK14 | |
| SCHEMBL30812495 | 0.81 | TGFBR1 (0.68) | TGFBR1MAPK14 | |
| SCHEMBL12096370 | 0.79 | TGFBR1 (0.65) | TGFBR1MAPK14 | |
| SCHEMBL23091679 | 0.78 | TGFBR1 (0.64) | TGFBR1MAPK14 | |
| SCHEMBL3244123 | 0.78 | TGFBR1 (0.63) | TGFBR1MAPK14 | |
| SCHEMBL18642502 | 0.77 | GRM4 (0.65) | TGFBR1MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122038285-A | Kit and method for constructing human bone organ by using pluripotent stem cells | 广东医科大学附属医院 | 2026-05-15 | — | — | CN | claimed |
| US-20260049275-A1 | INDUCED STEM CELLS | UNIV MONASH (AU) | 2026-02-19 | — | — | US | claimed |
| EP-3350313-B1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR (SG) | 2025-11-26 | — | — | EP | claimed |
| EP-3047017-B1 | METHODS OF MAMMALIAN RETINAL STEM CELL PRODUCTION AND APPLICATIONS | UNIV CALIFORNIA (US) | 2025-09-10 | — | — | EP | claimed |
| US-12371664-B2 | Medium for direct differentiation of pluripotent stem cell-derived mesenchymal stem cell, method for preparing mesenchymal stem cell by using same, and mesenchymal stem cell prepared thereby | CHA BIOTECH CO., LTD. (KR) | 2025-07-29 | — | — | US | claimed |
| WO-2025097221-A1 | OPTIMIZED METHOD FOR GENERATING HUMAN SKIN ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | THE UNIVERSITY OF QUEENSLAND (AU) | 2025-05-15 | — | — | WO | claimed |
| US-RE50313-E1 | Musculoskeletal stem cell and medium for inducing differentiation of musculoskeletal stem cell | CELLATOZ THERAPEUTICS, INC. (KR) | 2025-02-25 | — | — | US | claimed |
| CN-118853572-A | Culture medium for inducing amniotic epithelial cells to differentiate into neural stem cells and induction method | 西安东澳生物科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-12065671-B2 | Method for reproducible differentiation of clinical-grade retinal pigment epithelium cells | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-08-20 | — | — | US | claimed |
| US-20240271089-A1 | METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-08-15 | — | — | US | claimed |
| US-8883502-B2 | Expandable cell source of neuronal stem cell populations and methods for obtaining and using them | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-11-11 | — | — | US | claimed |
| EP-2799537-A1 | NORMALIZATION OF CULTURE OF CORNEAL ENDOTHELIAL CELLS | Kyoto Prefectural Public University Corporation (JP) | 2014-11-05 | — | — | EP | claimed |
| US-20140120621-A1 | TGF-BETA RECEPTOR INHIBITORS TO ENHANCE DIRECT REPROGRAMMING | THE GENERAL HOSPITAL CORPORATION (US) | 2014-05-01 | — | — | US | claimed |
| US-8603818-B1 | TGF-beta receptor inhibitors to enhance direct reprogramming | THE GENERAL HOSPITAL CORPORATION (US) | 2013-12-10 | — | — | US | claimed |
| US-20130236436-A1 | EXPANDABLE CELL SOURCE OF NEURONAL STEM CELL POPULATIONS AND METHODS FOR OBTAINING AND USNIG THEM | ZHANG KANG (US) | 2013-09-12 | — | — | US | claimed |
| US-20130071931-A1 | PROCESS FOR HEPATIC DIFFERENTIATION FROM INDUCED HEPATIC STEM CELLS, AND INDUCED HEPATIC PROGENITOR CELLS DIFFERENTIATED THEREBY | NATIONAL CANCER CENTER (JP) | 2013-03-21 | — | — | US | claimed |
| US-8298825-B1 | TGF-beta receptor inhibitors to enhance direct reprogramming | THE GENERAL HOSPITAL CORPORATION (US) | 2012-10-30 | — | — | US | claimed |
| EP-2497825-A1 | Novel method for rapid and efficient generation of neuroectoderm cells and peripheral neurons from pluripotent stem cells | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2012-09-12 | — | — | EP | claimed |
| US-20120142093-A1 | METHOD FOR INDUCING DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO NEURAL PRECURSOR CELLS | KYOTO UNIVERSITY (JP) | 2012-06-07 | — | — | US | claimed |
| US-20120058949-A1 | Methods of Treating Neurological Disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2012-03-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049275-A1 | INDUCED STEM CELLS | SALL4, SOX18, LEF1 | TGFBR1 110/4885MAPK14 664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.